You cannot predict a bleeding event, but you can prepare for one.

Life is unpredictable – a bleeding injury can occur without warning and the ability to quickly control blood loss can make all the difference.
 
Uncontrolled bleeding is a major cause of preventable deaths. Approximately 40% of trauma-related deaths worldwide are due to bleeding or its consequences, establishing hemorrhage as the most common cause of preventable death in trauma.
 
QuikClot® hemostatic devices can stop bleeding faster, more effectively and without excessive costs. QuikClot® Bleeding Control Bags and Kits provide life-saving technology and the ability to treat multiple injuries should an event occur.

Learn more about QUIKCLOT®


QuikClot® devices are more effective than standard gauze

As simple and easy to use as standard gauze, QuikClot® devices, applied with manual pressure, control severe bleeding faster because they contain kaolin.1-5 Kaolin is a mineral known for more than half a century to clot blood.7 Unlike other hemostatic products, QuikClot® devices do not contain animal or human proteins which can trigger allergic reactions that can become additional emergencies.

Watch how QuikClot® works


Knowing the facts

Mass casualty events — acts of terrorism, natural disasters, or intentional acts of violence – require certain preparedness and response. Using QuikClot® products in these situations can save lives by controlling bleeding.

Since 1999, 91 mass casualty events have been recorded. These tragedies have resulted in the death of 3,487 individuals and injuries to nearly 7,000 more.14


A study of 160 active shooter events in the United States between 2000-2013.15


Request More Information


Hemorrhage accounts for over 35% of pre-hospital deaths and 40% of deaths within the first 24 hours following traumatic injuries.16

Advanced preparedness ensures you have the right medical products to control bleeding when injuries occur. Hospitals, EMS, First Responders, Law Enforcement and the U.S. Military all use QuikClot® products.


How can we serve you better?

Let us help assess the bleeding control needs of your team, department, or entire facility. We can recommend the QuikClot® devices that are right for the situations you may encounter.

Contact us

References: 1. Trabattoni D, Montorsi P, Fabbiocchi F, Lualdi A, Gatto P, Bartorelli A. A new kaolin-based haemostatic bandage compared with manual compression for bleeding control after percutaneous coronary procedures. Eur Radiol. 2011;21:1687-1691. 2. Politi L, Aprile A, Paganelli C, et al. Randomized clinical trial on short-time compression with kaolin-filled pad: a new strategy to avoid early bleeding and subacute radial artery occlusion after percutaneous coronary intervention. J Interven Cardiol. 2011;24:65-72. 3. Trabattoni D, Gatto P, Bartorelli A. A new kaolin-based hemostatic bandage use after coronary diagnostic and interventional procedures. Int J Cardiol. 2012;156(1):53-54. 4. Lamb KM, Pitcher HT, Cavarocchi NC, Hirose H. Vascular site hemostasis in percutaneous extracorporeal membrane oxygenation therapy. Open Cardiovasc Thorac Surg J. 2012;5:8-10. 5. Pahari M, Moliver R, Lo D, Pinkerton D, Basadonna G. QuikClot® Interventional™ Hemostatic Bandage (QCI): a novel hemostatic agent for vascular access. Cath Lab Digest. 2010;18(1):28-30. http://www.cathlabdigest.com/articles/QuikClot®-Interventional™-Hemostatic-Bandage-QCI-A-Novel-Hemostatic-Agent-Vascular-Access. Accessed on August 10, 2014. 6. Tactical Combat Casualty Care Guidelines 2 June 2014. http://www.usaisr.amedd.army.mil/pdfs/TCCC_Guidelines_140602.pdf. Accessed March 25, 2015. 7. Margolis J. Initiation of blood coagulation by glass and related surfaces. Journal Physiol 1957;137:95-109. 8. Data on file. 9. Curry N, Hopewell S, Doree C, Hyde C, Brohi K, Stanworth S. The acute management of trauma hemorrhage: a systematic review of randomized controlled trials. Crit Care. 2011;15(2):R92. 10. Kheirabadi BS, Mace JE, Terrazas IB, et al. Safetry evaluation of new hemostatic agents, smectite granules, and kaolin covered gauze in vascular injury wound model in swine. J Trauma. 2010;68:269-278. 11. Kheirabadi BS, Scherer MR, Estep JS, Dubick MA, Holcomb JB. Determination of efficacy of new hemostatic dressing in a model of extremity arterial hemorrhage in swine. J Trauma. 2009;67:450-460. 12. Kheirabadi BS. Evaluation of topical hemostatic agents for combat wound treatment. US Army Med Dep J. 2011;25-37. 13. Dee KC, Puleo DA, Bizios R. Tissue-Biomaterial Interactions. Hoboken: Wiley & Sons, 2002. 14. Stop the Bleeding Coalition website http://www.stopthebleedingcoalition.com/get-the-facts.html. Updated: 18 July 2014. Accessed 24 February 2016. 15. Blair, J. Pete, and Schweit, Katherine W. (2014). A Study of Active Shooter Incidents, 2000 - 2013. Texas State University and Federal Bureau of Investigation, US Department of Justice, Washington D.C. 2014. 16. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006; 60:S3-S11.

Show ReferencesHide References


 

Our site includes links to third party sites in which the Z-Medica® Privacy Policy and Terms of Use do not apply. Please read the privacy policy for every third party website you visit.

Continue